GB9015908D0 - Multivalent immunoglobulin - Google Patents

Multivalent immunoglobulin

Info

Publication number
GB9015908D0
GB9015908D0 GB909015908A GB9015908A GB9015908D0 GB 9015908 D0 GB9015908 D0 GB 9015908D0 GB 909015908 A GB909015908 A GB 909015908A GB 9015908 A GB9015908 A GB 9015908A GB 9015908 D0 GB9015908 D0 GB 9015908D0
Authority
GB
United Kingdom
Prior art keywords
multivalent immunoglobulin
multivalent
immunoglobulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB909015908A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Celltech Ltd
Original Assignee
Celltech R&D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celltech R&D Ltd filed Critical Celltech R&D Ltd
Priority to GB909015908A priority Critical patent/GB9015908D0/en
Publication of GB9015908D0 publication Critical patent/GB9015908D0/en
Priority to KR1019930700150A priority patent/KR930701192A/en
Priority to EP91913265A priority patent/EP0539455A1/en
Priority to CA002087541A priority patent/CA2087541A1/en
Priority to AU82381/91A priority patent/AU8238191A/en
Priority to PCT/GB1991/001216 priority patent/WO1992001472A1/en
Priority to JP3512563A priority patent/JPH06501840A/en
Priority to NO93930153A priority patent/NO930153L/en
Priority to GB9300960A priority patent/GB2261666B/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB909015908A 1990-07-19 1990-07-19 Multivalent immunoglobulin Pending GB9015908D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GB909015908A GB9015908D0 (en) 1990-07-19 1990-07-19 Multivalent immunoglobulin
KR1019930700150A KR930701192A (en) 1990-07-19 1991-07-19 Multivalent anti-cytokine immunoglobulins
EP91913265A EP0539455A1 (en) 1990-07-19 1991-07-19 Multivalent anti-cytokine immunoglobulins
CA002087541A CA2087541A1 (en) 1990-07-19 1991-07-19 Multivalent anti-cytokine immunoglobulins
AU82381/91A AU8238191A (en) 1990-07-19 1991-07-19 Multivalent anti-cytokine immunoglobulins
PCT/GB1991/001216 WO1992001472A1 (en) 1990-07-19 1991-07-19 Multivalent anti-cytokine immunoglobulins
JP3512563A JPH06501840A (en) 1990-07-19 1991-07-19 Multivalent anti-cytokine immunoglobulin
NO93930153A NO930153L (en) 1990-07-19 1993-01-18 MULTIPLE ANTI-CYTOCHINE IMMUNOGLOBULINES
GB9300960A GB2261666B (en) 1990-07-19 1993-01-19 Multivalent anti-cytokine immunoglobulins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909015908A GB9015908D0 (en) 1990-07-19 1990-07-19 Multivalent immunoglobulin

Publications (1)

Publication Number Publication Date
GB9015908D0 true GB9015908D0 (en) 1990-09-05

Family

ID=10679355

Family Applications (2)

Application Number Title Priority Date Filing Date
GB909015908A Pending GB9015908D0 (en) 1990-07-19 1990-07-19 Multivalent immunoglobulin
GB9300960A Expired - Fee Related GB2261666B (en) 1990-07-19 1993-01-19 Multivalent anti-cytokine immunoglobulins

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB9300960A Expired - Fee Related GB2261666B (en) 1990-07-19 1993-01-19 Multivalent anti-cytokine immunoglobulins

Country Status (7)

Country Link
EP (1) EP0539455A1 (en)
JP (1) JPH06501840A (en)
KR (1) KR930701192A (en)
AU (1) AU8238191A (en)
CA (1) CA2087541A1 (en)
GB (2) GB9015908D0 (en)
WO (1) WO1992001472A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277969B1 (en) 1991-03-18 2001-08-21 New York University Anti-TNF antibodies and peptides of human tumor necrosis factor
US7192584B2 (en) 1991-03-18 2007-03-20 Centocor, Inc. Methods of treating psoriasis with anti-TNF antibodies
US6284471B1 (en) 1991-03-18 2001-09-04 New York University Medical Center Anti-TNFa antibodies and assays employing anti-TNFa antibodies
US6180377B1 (en) * 1993-06-16 2001-01-30 Celltech Therapeutics Limited Humanized antibodies
US5478753A (en) * 1993-06-29 1995-12-26 Pb Diagnostic Systems, Inc. Positive calibrator/control composition for an IgM serology assay and an IgM serology assay
FR2707882B1 (en) * 1993-07-23 1997-08-01 Immunotech Sa New protein anti-mediator therapeutic kits, preparation process and pharmaceutical compositions containing them.
GB2281300A (en) * 1993-08-26 1995-03-01 Merck & Co Inc Anti-HIV antibody oligomer
WO1996003141A1 (en) * 1994-07-22 1996-02-08 F. Hoffmann-La Roche Ag Pharmaceutical compositions comprising a chimaeric tnf binding protein
TW555765B (en) 1996-07-09 2003-10-01 Amgen Inc Low molecular weight soluble tumor necrosis factor type-I and type-II proteins
AU5696198A (en) 1996-12-06 1998-06-29 Amgen, Inc. Combination therapy using a tnf binding protein for treating tnf-mediated diseases
US20040220103A1 (en) 1999-04-19 2004-11-04 Immunex Corporation Soluble tumor necrosis factor receptor treatment of medical disorders
AU3082401A (en) * 1999-11-24 2001-06-04 Centocor Inc. Therapy of psoriasis
TWI327597B (en) 2001-08-01 2010-07-21 Centocor Inc Anti-tnf antibodies, compositions, methods and uses
US9028822B2 (en) 2002-06-28 2015-05-12 Domantis Limited Antagonists against TNFR1 and methods of use therefor
US10689449B2 (en) 2015-01-20 2020-06-23 Igm Biosciences, Inc. Multimeric death domain-containing receptor-5 (DR5) antibodies and uses thereof
EP3340995A4 (en) 2015-08-28 2019-04-03 The Trustees Of The University Of Pennsylvania Methods and compositions for cells expressing a chimeric intracellular signaling molecule
EP3340998B1 (en) 2015-08-28 2023-01-11 The Trustees of the University of Pennsylvania Methods and compositions for cells expressing a chimeric intracellular signaling molecule
US10465003B2 (en) 2016-02-05 2019-11-05 Janssen Biotech, Inc. Anti-TNF antibodies, compositions, methods and use for the treatment or prevention of type 1 diabetes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989011864A1 (en) * 1988-05-31 1989-12-14 Schering Biotech Corporation Method of treating myeloid leukemias
AU4182289A (en) * 1988-08-19 1990-03-23 Celltech Limited Pharmaceutical products for anti-neoplastic therapy
AU4035189A (en) * 1988-08-19 1990-03-23 Upjohn Company, The Renin inhibitory peptides containing suleptanic acid or derivatives thereof
FR2640146B1 (en) * 1988-12-08 1993-12-24 Commissariat A Energie Atomique ANTI-INTERLEUKIN MONOCLONAL ANTIBODIES 1 (ALPHA) AND 1 (BETA), THEIR PRODUCTION METHOD AND APPLICATIONS OF SAID ANTIBODIES TO DETECTION OF INTERLEUKINS 1 (ALPHA) AND 1 (BETA) AND THERAPEUTICS
FR2640143B1 (en) * 1988-12-13 1991-03-15 Maes Ludo POLYMERIZED ANTIBODIES, DIRECTED AGAINST IMMUNOGLOBULINS - THEIR USE IN DIAGNOSTIC TESTS
WO1991006305A1 (en) * 1989-11-07 1991-05-16 Bristol-Myers Squibb Company Oligomeric immunoglobulins

Also Published As

Publication number Publication date
GB2261666B (en) 1994-07-27
KR930701192A (en) 1993-06-11
EP0539455A1 (en) 1993-05-05
GB2261666A (en) 1993-05-26
AU8238191A (en) 1992-02-18
WO1992001472A1 (en) 1992-02-06
CA2087541A1 (en) 1992-01-20
JPH06501840A (en) 1994-03-03
GB9300960D0 (en) 1993-03-17

Similar Documents

Publication Publication Date Title
GB2250995B (en) Multivalent antigen-binding proteins
EP0547137A4 (en) Homoconjugated immunoglobulins
GB9116945D0 (en) Oxorapamycin
GB9015908D0 (en) Multivalent immunoglobulin
EP0476147A4 (en) Mini-golf course
GB2243403B (en) Stay
AU111085S (en) Sunlounger
DE4092685D2 (en) Mehrkomponenten-kleb- und -werkstoffverarbeitungssystem
GB9014652D0 (en) Antigen
GB9223676D0 (en) Modified antibodies
EP0550595A4 (en) Methods
GB9019779D0 (en) Elongate joints between elongate members
EP0439820A3 (en) Vacuumswitch
GB9115010D0 (en) Antibody
AU110900S (en) Facsimilie
DE4191594D2 (en) Sicherheitsgurtverschluss
AU109294S (en) Listello
GB9026708D0 (en) Step-stool
GB9013419D0 (en) Antibodies
CA66168S (en) Récipient
AU157P (en) SUNFLARE Telopea speciosissima
GB9117602D0 (en) Novel antigens
GB9122301D0 (en) Novel antigens
GB9009560D0 (en) Structural element
CS639190A3 (en) Tubular collecting-electrodes